Early-onset Cardiotoxicity assessment related to anthracycline in children with leukemia. A Prospective Study

Background: Acute leukemias are the most frequent malignancies in children. Advances in treatment have improved the overall survival to 80%. Almost 10% of children with cancer develop clinical cardiac toxicity. Total anthracycline cumulative dose is a risk factor for early-onset cardiotoxicity.Obje...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Colombia Médica
Päätekijät: Adriana Linares Ballesteros, Roy Sanguino Lobo, Juan Camilo Villada Valencia, Oscar Arévalo Leal, Diana Constanza Plazas Hernández, Nelson Aponte Barrios, Iván Perdomo Ramírez
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Universidad del Valle 2021
Aiheet:
Medicina
Child
leukemia
drug therapy
anthracyclines
echocardiography
Linkit:https://www.redalyc.org/articulo.oa?id=28366572004
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia